Public Policy Should Foster Alzheimer's Treatment Availability: Comment on the Draft US Medicare Decision to Limit Payment for Aducanumab (AduhelmTM) to Patients Participating in Clinical Trials.
作者信息
Cummings J
机构信息
Jeffrey Cummings, MD, ScD, 1380 Opal Valley Street, Henderson, NV 89052,
出版信息
J Prev Alzheimers Dis. 2022;9(2):241-246. doi: 10.14283/jpad.2022.25.
Abstract
摘要
Zotero 插件